NCT02129179View on ClinicalTrials.gov

The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Heart Failure

Interventions

DRUG

Glucagon-Like Peptide 1

Trial Locations (1)

CB23 3RE

Papworth Hospital NHS Foundation Trust, Papworth Everard

All Listed Sponsors

lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV

NCT02129179 - The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure | Biotech Hunter | Biotech Hunter